Article
MIT Technology Review
(2019)
The gene-editing tool has been used in a trial to enhance the blood cells of two patients with cancer, according to NPR.
FoundryBase
updated 9 months ago
0 likes
MORE RESOURCES FROM SOURCE
More from FoundryBase MIT Technology Review